Company intelligence / Profile preview

ThirdGate Capital

Charlottesville, Virginia, USA

Ownership: Private
Development stage: Other

Overview

ThirdGate Capital is a boutique investment and advisory firm specializing in the healthcare and life sciences industries. Based in Charlottesville, Virginia, the firm focuses on identifying and developing high-value opportunities within biotechnology and pharmaceuticals. It is closely integrated with the leadership of Biovista, utilizing advanced data analytics and systematic drug repositioning strategies to evaluate therapeutic assets. ThirdGate Capital provides strategic guidance on clinical development, regulatory pathways, and market positioning for its portfolio interests and clients. The firm leverages deep domain expertise to bridge the gap between scientific innovation and commercial success. Its activities often involve scouting for undervalued drug candidates that can be repurposed for new indications.

Industry: Investors

Partnerships

Biovista

Beyond the preview

Go deeper on ThirdGate Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ThirdGate Capital.

Explore the full profile